Combined mucoactive therapy of diseases of the respiratory system associated with formation of a viscous secretion in children
Journal Title: Здоров`я дитини - Year 2017, Vol 12, Issue 2
Abstract
The article considers in detail the mechanisms of therapeutic action of various mucoactive agents. Modern approaches to mucoactive therapy of respiratory diseases in children are presented, they are accompanied by the formation of a viscous secretion. At the same time, the expediency of combined use of drugs having different mechanism of mucoactive action — ambroxol and carbocysteine is justified. In addition, it helps to increase the effectiveness of antibiotic therapy for respiratory diseases.
Authors and Affiliations
S. P. Kryvopustov
Gilbert’s Syndrome: Terminology, Epidemiology, Genetics, Pathogenesis (Part I)
The aim of the review was the analysis of the literature about the prevalence, etiology, genetics and pathogenesis of Gilbert’s syndrome (GS). The scientific literature regarding GS with the keywords «Gilbert's syndrome»...
Predicting the development of acute bacterial bronchitis in young children
Seventy four young children with acute bronchitis (34 — with viral bronchitis and 40 with bacterial bronchitis) were examined using Acute Bronchitis Severity Score, with a bacteriological study of nasopharyngeal aspirate...
Risk Factors for Pathology of the Upper Gastrointestinal Tract in Children with Bronchial Asthma
Objective: to create a model for predicting the risk of upper gastrointestinal diseases in children with bronchial asthma. Material and Methods. The study included 120 children with bronchial asthma, 78 of them had conco...
Ways to Correct the Disorders of the Functional State of the Gastrointestinal Tract in Helminthiasis in Children
The course of enterobiasis and ascariasis in the examined 30 children aged 3 to 4 years has been characterized by the dysfunction of the gastrointestinal tract in the form of functional dyspepsia and functional disorders...
Comparing the dynamics of biomarkers of neuron-specific enolase and S-100 protein in neonates with hypoxic-ischemic encephalopathy, depending on the start of therapeutic hypothermia (0–6 h vs. 6–24 h after delivery)
Background. To date, it remains unclear whether serum levels of neuron-specific enolase (NSE) and S-100 protein definitely correspond to the severity and possible outcomes of hypoxic-ischemic encephalopathy (HIE), as wel...